BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27075335)

  • 1. Alternative Polyadenylation: Another Foe in Cancer.
    Erson-Bensan AE; Can T
    Mol Cancer Res; 2016 Jun; 14(6):507-17. PubMed ID: 27075335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative polyadenylation and RNA-binding proteins.
    Erson-Bensan AE
    J Mol Endocrinol; 2016 Aug; 57(2):F29-34. PubMed ID: 27208003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the function and relevance of alternative 3'-UTRs in gene expression regulation.
    Pereira-Castro I; Moreira A
    Wiley Interdiscip Rev RNA; 2021 Sep; 12(5):e1653. PubMed ID: 33843145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of alternative polyadenylation to the cancer phenotype.
    Masamha CP; Wagner EJ
    Carcinogenesis; 2018 Jan; 39(1):2-10. PubMed ID: 28968750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative Polyadenylation in Triple-Negative Breast Tumors Allows NRAS and c-JUN to Bypass PUMILIO Posttranscriptional Regulation.
    Miles WO; Lembo A; Volorio A; Brachtel E; Tian B; Sgroi D; Provero P; Dyson N
    Cancer Res; 2016 Dec; 76(24):7231-7241. PubMed ID: 27758885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative cleavage and polyadenylation: extent, regulation and function.
    Elkon R; Ugalde AP; Agami R
    Nat Rev Genet; 2013 Jul; 14(7):496-506. PubMed ID: 23774734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcellular RNA profiling links splicing and nuclear DICER1 to alternative cleavage and polyadenylation.
    Neve J; Burger K; Li W; Hoque M; Patel R; Tian B; Gullerova M; Furger A
    Genome Res; 2016 Jan; 26(1):24-35. PubMed ID: 26546131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCL1 alternative polyadenylation is essential for cell survival and mitochondria morphology.
    Pereira-Castro I; Garcia BC; Curinha A; Neves-Costa A; Conde-Sousa E; Moita LF; Moreira A
    Cell Mol Life Sci; 2022 Mar; 79(3):164. PubMed ID: 35229202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative Polyadenylation Patterns for Novel Gene Discovery and Classification in Cancer.
    Begik O; Oyken M; Cinkilli Alican T; Can T; Erson-Bensan AE
    Neoplasia; 2017 Jul; 19(7):574-582. PubMed ID: 28624626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CFIm25 and alternative polyadenylation: Conflicting roles in cancer.
    Jafari Najaf Abadi MH; Shafabakhsh R; Asemi Z; Mirzaei HR; Sahebnasagh R; Mirzaei H; Hamblin MR
    Cancer Lett; 2019 Sep; 459():112-121. PubMed ID: 31181319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative Polyadenylation of
    Qin X; Meng C; Li C; Zhao W; Ren S; Cao S; Zhou G
    J Agric Food Chem; 2023 Dec; 71(51):20815-20825. PubMed ID: 38088871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dynamic interplay between alternative polyadenylation and microRNA regulation: implications for cancer (Review).
    An J; Zhu X; Wang H; Jin X
    Int J Oncol; 2013 Oct; 43(4):995-1001. PubMed ID: 23913120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive analysis of 3' end sequencing data sets reveals novel polyadenylation signals and the repressive role of heterogeneous ribonucleoprotein C on cleavage and polyadenylation.
    Gruber AJ; Schmidt R; Gruber AR; Martin G; Ghosh S; Belmadani M; Keller W; Zavolan M
    Genome Res; 2016 Aug; 26(8):1145-59. PubMed ID: 27382025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide profiling of polyadenylation sites reveals a link between selective polyadenylation and cancer metastasis.
    Lai DP; Tan S; Kang YN; Wu J; Ooi HS; Chen J; Shen TT; Qi Y; Zhang X; Guo Y; Zhu T; Liu B; Shao Z; Zhao X
    Hum Mol Genet; 2015 Jun; 24(12):3410-7. PubMed ID: 25759468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hnRNPC regulates cancer-specific alternative cleavage and polyadenylation profiles.
    Fischl H; Neve J; Wang Z; Patel R; Louey A; Tian B; Furger A
    Nucleic Acids Res; 2019 Aug; 47(14):7580-7591. PubMed ID: 31147722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying alternative polyadenylation in RNAseq data with LABRAT.
    Gillen AE; Goering R; Taliaferro JM
    Methods Enzymol; 2021; 655():245-263. PubMed ID: 34183124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between NUDT21 mediated alternative polyadenylation process and tumor.
    Xiao S; Gu H; Deng L; Yang X; Qiao D; Zhang X; Zhang T; Yu T
    Front Oncol; 2023; 13():1052012. PubMed ID: 36816917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant Alternative Polyadenylation is Responsible for Survivin Up-regulation in Ovarian Cancer.
    He XJ; Zhang Q; Ma LP; Li N; Chang XH; Zhang YJ
    Chin Med J (Engl); 2016 May; 129(10):1140-6. PubMed ID: 27174320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of alternative cleavage and polyadenylation in mature and differentiating neurons using RNA-seq data.
    Guvenek A; Tian B
    Quant Biol; 2018 Sep; 6(3):253-266. PubMed ID: 31380142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of miRNAs and alternative mRNA 3'-end cleavage and polyadenylation of their mRNA targets in cardiomyocyte hypertrophy.
    Soetanto R; Hynes CJ; Patel HR; Humphreys DT; Evers M; Duan G; Parker BJ; Archer SK; Clancy JL; Graham RM; Beilharz TH; Smith NJ; Preiss T
    Biochim Biophys Acta; 2016 May; 1859(5):744-56. PubMed ID: 27032571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.